跳至主要内容
临床试验/CTRI/2021/06/034115
CTRI/2021/06/034115尚未招募1 期

Single Institutional Pilot Study Of Low Dose Whole Lung Radiation Therapy In Moderate To Severe COVID-19 Pneumonia Patients.

ot yet applied0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient with informed consent
  • 2. Age >18 yrs and <90 yrs
  • 3. COVID-19 RT-PCR positive
  • 4. RT-PCR done less than 7days
  • 5. Moderate to severe case (NEWS 2 score- more than or equal to 5)
  • 6. SPO2- <90%, RR- >24 per minute in Room air
  • 7. KPS >60
  • 8. HRCT suggestive of Interstitial pneumonia with CORADS 4-6 and CT severity score of moderate to severe.
  • 9. Patient able to lie supine for Radiation therapy

排除标准

  • 1. Patient on mechanical ventilator support
  • 2. Hemodynamically unstable patient
  • 3. Pregnancy and lactating mothers
  • 4. Known prior systemic use of the following drugs: Bleomycin, Carmustine, Methotrexate, Busulfan,Cyclophosphamide, or Amiodarone
  • 5. History of lung lobectomy or pneumonectomy.
  • 6. History of receiving immunotherapy within the past 6 months.
  • 7. History of Chronic obstructive pulmonary disease, Severe Left Ventricular Dysfunction and patients on beta blockers.

研究者

发起方
ot yet applied

相似试验